BFS
COLL icon

Bradley Foster & Sargent’s Collegium Pharmaceutical COLL Stock Holding History

Bradley Foster & Sargent’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-32,185
Closed -$403K – 356
2017
Q2 		$403K Buy
+32,185
New +$318K 0.02% 280

Other funds holding COLL

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bradley Foster & Sargent's COLL Position: Q3 2017 in Review

Bradley Foster & Sargent sold out of Collegium Pharmaceutical (COLL) in Q3 2017, closing a stake of 32,185 shares — an estimated $403K sold.

Bradley Foster & Sargent first reported a position in COLL in Q2 2017 and held it in 1 quarter. The position peaked at $403K in Q2 2017. 75 funds tracked by Wall St. Rank hold COLL as of Q3 2017.

  • Bradley Foster & Sargent reported no remaining Collegium Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • Bradley Foster & Sargent sold 32,185 Collegium Pharmaceutical shares in Q3 2017, an estimated $403K.
  • Bradley Foster & Sargent first reported a position in Collegium Pharmaceutical in Q2 2017 and held it in 1 quarter.
  • Bradley Foster & Sargent's Collegium Pharmaceutical position peaked at $403K in Q2 2017.
  • 75 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2017.

Based on Bradley Foster & Sargent's 13F filing for Q3 2017, filed 3 Nov 2017.